arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

MapLight Therapeutics, Inc.

MPLT Health Care Biotechnology: Pharmaceutical Preparations
$14.00
▲ +1.7% Today
as of Sep 4, 16:51 ET
Last 30 days +39.02% Jul 27 → Sep 04
$9.50 $10.98 $12.46 $13.95 $15.43 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$13.03
High
$14.14
Low
$13.00
Volume
$550,854
Avg Vol
$456,409
Mkt Cap
$543M
P/E (TTM)
—
Beta
—
52w High
$40.43
52w Low
$9.10
Div Yield
—
Shares Out
$45M

Recent Press Releases & News last 60 days · 18 items

Aug 13 · 20:05 PR GlobeNewswire
MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 13 · 13:47 MT Newswires
MapLight Therapeutics Launching $150 Million Private Placement Financing
Aug 13 · 13:10 PR GlobeNewswire
MapLight Therapeutics Announces $150 Million Private Placement Financing
▸ Show all 18 press releases & news Free account →

Overview

52-week range
$9.10
$40
16% of range
Avg surprise (last 1)
-47.2%
Avg reaction (last 1)
-4.5%
0% positive
Latest IV / EM
133%
EM ±20.7% · $15 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-39.11$-29.56$-20.01$-10.46$-0.91 Actual $-25.08Actual $-29.33Actual $-39.11Actual $-37.18Actual $-1.34Est $-0.91Actual $-1.32 SepMarJunSepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-61M$-50M$-40M$-30M$-20M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.32 — — — — financials
Thu May 14, 2026Mar/2026 $-1.34 $-0.91 -47.2% — -4.5% earnings
Tue Sep 30, 2025Sep 2025 $-37.18 — — — — financials
Mon Jun 30, 2025Jun 2025 $-39.11 — — — — financials
Mon Mar 31, 2025Mar 2025 $-29.33 — — — — financials
Mon Sep 30, 2024Sep 2024 $-25.08 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-64M$-65M—$-31M$-31M$-24M—$-21M
Net income$-60M$-61M—$-29M$-30M$-22M—$-19M
EPS (diluted)$-1.32$-1.34—$-37.18$-39.11$-29.33—$-25.08

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$72M$56M$47M$64M——$38M—
Inventory————————
Total current assets$319M$327M$325M$245M——$115M—
Total assets$368M$419M$480M$257M——$137M—
Long-term debt————————
Total liabilities$20M$19M$21M$24M——$22M—
Total equity$348M$400M$458M$-274M$-245M$-216M$-194M$-172M

Implied volatility — last 90 days

68%187%306%425%543% Jun 07 — IV 157% · EM ±21.8%Jun 08 — IV 139% · EM ±18.3%Jun 09 — IV 142% · EM ±17.8%Jun 10 — IV 164% · EM ±19.4%Jun 11 — IV 149% · EM ±16.5%Jun 12 — IV 190% · EM ±19.5%Jun 15 — IV 267% · EM ±19.3%Jun 16 — IV 368% · EM ±21.7%Jun 17 — IV 410% · EM ±17.1%Jun 19 — IV 131% · EM ±29.0%Jun 22 — IV 135% · EM ±28.3%Jun 23 — IV 136% · EM ±27.8%Jun 24 — IV 147% · EM ±29.4%Jun 25 — IV 139% · EM ±27.2%Jun 26 — IV 144% · EM ±27.6%Jun 29 — IV 148% · EM ±26.3%Jun 30 — IV 151% · EM ±25.9%Jul 01 — IV 134% · EM ±22.4%Jul 02 — IV 144% · EM ±23.3%Jul 03 — IV 149% · EM ±23.3%Jul 06 — IV 176% · EM ±24.4%Jul 07 — IV 174% · EM ±22.9%Jul 08 — IV 197% · EM ±24.7%Jul 09 — IV 197% · EM ±23.2%Jul 10 — IV 213% · EM ±23.5%Jul 13 — IV 265% · EM ±22.1%Jul 14 — IV 327% · EM ±23.7%Jul 15 — IV 388% · EM ±22.9%Jul 16 — IV 405% · EM ±16.9%Jul 20 — IV 347% · EM ±82.0%Jul 21 — IV 343% · EM ±79.7%Jul 22 — IV 362% · EM ±82.7%Jul 23 — IV 368% · EM ±82.7%Jul 24 — IV 365% · EM ±80.6%Jul 27 — IV 178% · EM ±37.1%Jul 28 — IV 149% · EM ±30.5%Jul 29 — IV 83% · EM ±16.6%Jul 30 — IV 118% · EM ±23.1%Jul 31 — IV 174% · EM ±33.2%Aug 03 — IV 91% · EM ±16.1%Aug 04 — IV 83% · EM ±14.3%Aug 05 — IV 92% · EM ±15.3%Aug 06 — IV 85% · EM ±13.8%Aug 07 — IV 149% · EM ±23.3%Aug 10 — IV 123% · EM ±17.0%Aug 11 — IV 125% · EM ±16.5%Aug 12 — IV 203% · EM ±25.5%Aug 13 — IV 102% · EM ±12.1%Aug 14 — IV 166% · EM ±18.3%Aug 17 — IV 325% · EM ±27.1%Aug 18 — IV 205% · EM ±14.8%Aug 19 — IV 160% · EM ±9.5%Aug 20 — IV 544% · EM ±22.7%Aug 24 — IV 143% · EM ±29.9%Aug 25 — IV 75% · EM ±15.4%Aug 26 — IV 69% · EM ±13.8%Aug 27 — IV 95% · EM ±18.5%Aug 28 — IV 74% · EM ±14.1%Aug 31 — IV 98% · EM ±17.3%Sep 01 — IV 122% · EM ±21.0%Sep 02 — IV 113% · EM ±19.0%Sep 03 — IV 132% · EM ±21.3%Sep 04 — IV 133% · EM ±20.7%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in